NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Achilles Therapeutics plc (NASDAQ: ACHL)
ACHL Technical Analysis
5
As on 9th Jun 2023 ACHL STOCK Price closed @ 0.97 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.90 & Strong Sell for SHORT-TERM with Stoploss of 4.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ACHLSTOCK Price
Open | 1.01 | Change | Price | % |
High | 1.02 | 1 Day | -0.02 | -2.02 |
Low | 0.95 | 1 Week | -0.04 | -3.96 |
Close | 0.97 | 1 Month | 0.13 | 15.48 |
Volume | 64688 | 1 Year | -3.61 | -78.82 |
52 Week High 5.57 | 52 Week Low 0.79 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ACHL Daily Charts |
ACHL Intraday Charts |
Whats New @ Bazaartrend |
ACHL Free Analysis |
|
ACHL Important Levels Intraday
RESISTANCE | 1.10 |
RESISTANCE | 1.06 |
RESISTANCE | 1.03 |
RESISTANCE | 1.01 |
SUPPORT | 0.93 |
SUPPORT | 0.91 |
SUPPORT | 0.88 |
SUPPORT | 0.84 |
ACHL Forecast May 2024
4th UP Forecast | 4.79 |
3rd UP Forecast | 3.56 |
2nd UP Forecast | 2.81 |
1st UP Forecast | 2.05 |
1st DOWN Forecast | -0.11 |
2nd DOWN Forecast | -0.87 |
3rd DOWN Forecast | -1.62 |
4th DOWN Forecast | -2.85 |
ACHL Weekly Forecast
4th UP Forecast | 2.28 |
3rd UP Forecast | 1.86 |
2nd UP Forecast | 1.60 |
1st UP Forecast | 1.34 |
1st DOWN Forecast | 0.60 |
2nd DOWN Forecast | 0.34 |
3rd DOWN Forecast | 0.08 |
4th DOWN Forecast | -0.34 |
ACHL Forecast2024
4th UP Forecast | 10.41 |
3rd UP Forecast | 7.38 |
2nd UP Forecast | 5.51 |
1st UP Forecast | 3.64 |
1st DOWN Forecast | -1.7 |
2nd DOWN Forecast | -3.57 |
3rd DOWN Forecast | -5.44 |
4th DOWN Forecast | -8.47 |
Achilles Therapeutics plc ( NASDAQ USA Symbol : ACHL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ACHL Other Details
Segment | EQ | |
Market Capital | 249305488.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ACHL Address
ACHL Latest News
ACHL Business Profile
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various types of solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was founded in 2016 and is headquartered in London, the United Kingdom. Address: 245 Hammersmith Road, London, United Kingdom, W6 8PW
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service